Institutional Ownership Cue Biopharma, Inc. (CUE)
This table provides information about the institutional ownership of Cue Biopharma, Inc. (CUE). We have compiled data on the 52 institutions that hold shares in the stock, with a total of 14.1 Million shares, which have been reported (via 13F filing form) to have a value of $17.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bleichroeder LP
New York, NY |
Nov 13, 2024 Q3 2024 |
4,997,240
shares
|
$6.2 Million
1.28% of portfolio
|
Q3 2024
Added 74.63%
|
|
|
Slate Path Capital LP
New York, NY |
Nov 14, 2024 Q3 2024 |
2,402,455
shares
|
$2.98 Million
0.03% of portfolio
|
Q4 2022
Added 61.93%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
2,031,421
shares
|
$2.52 Million
0.0% of portfolio
|
Q2 2024
Reduced 11.03%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
756,736
shares
|
$938,352
0.0% of portfolio
|
Q2 2024
Reduced 66.28%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
508,827
shares
|
$630,945
0.0% of portfolio
|
Q3 2024
Added 3.32%
|
|
|
Robertson Stephens Wealth Management, LLC
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
478,500
shares
|
$593,340
0.01% of portfolio
|
Q1 2021
Reduced 1.14%
|
|
|
Sigma Planning Corp
Ann Arbor, MI |
Nov 01, 2024 Q3 2024 |
401,325
shares
|
$497,643
0.01% of portfolio
|
Q3 2024
Added 50.86%
|
|
|
Good Life Advisors, LLC
|
Oct 16, 2024 Q3 2024 |
400,000
shares
|
$496,000
0.02% of portfolio
|
Q3 2024
Added 23.08%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
358,974
shares
|
$445,127
0.0% of portfolio
|
Q3 2024
Reduced 27.33%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
291,663
shares
|
$361,662
0.02% of portfolio
|
Q3 2024
Added 5.08%
|
|
|
Advisory Research Inc
Chicago, IL |
Nov 13, 2024 Q3 2024 |
257,225
shares
|
$318,959
0.04% of portfolio
|
Q4 2021
Added 0.48%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
239,202
shares
|
$296,610
0.0% of portfolio
|
Q3 2024
Reduced 1.39%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Nov 14, 2024 Q3 2024 |
194,222
shares
|
$240,835
0.0% of portfolio
|
Q3 2024
Added 0.12%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
177,053
shares
|
$219,545
0.0% of portfolio
|
Q2 2024
Reduced 76.7%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
138,314
shares
|
$171,509
0.0% of portfolio
|
Q3 2024
Reduced 60.53%
|
|
|
High Tower Advisors, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
83,284
shares
|
$103,272
0.0% of portfolio
|
Q2 2024
Added 7.46%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
74,175
shares
|
$91,977
0.0% of portfolio
|
Q3 2024
Added 25.69%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
33,692
shares
|
$41,778
0.0% of portfolio
|
Q3 2024
Reduced 72.16%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
27,665
shares
|
$34,304
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
25,935
shares
|
$32,159
0.0% of portfolio
|
Q3 2024
Reduced 73.7%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
24,672
shares
|
$30,593
0.0% of portfolio
|
Q3 2024
Reduced 69.25%
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Nov 14, 2024 Q3 2024 |
24,098
shares
|
$29,881
0.0% of portfolio
|
Q3 2024
Reduced 54.56%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
20,077
shares
|
$24,895
0.0% of portfolio
|
Q3 2024
Reduced 2.93%
|
|
|
Cambridge Investment Research Advisors, Inc.
|
Oct 28, 2024 Q3 2024 |
20,000
shares
|
$24,800
0.0% of portfolio
|
Q3 2024
Reduced 9.91%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
18,563
shares
|
$23,018
0.0% of portfolio
|
Q3 2024
Reduced 93.03%
|